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Increased expression of TGF-/31 mRNA in the obstructed
kidney of rats with unilateral ureteral ligation
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Increased expression of TGF-131 in the obstructed kidney of rats with
unilateral ureteral ligation. Renal interstitial fibrosis is a common
consequence of chronic ureteral obstruction. While several cytokines
may initiate fibrogenesis, TGF-/3 is considered to be a major stimulating
factor. It has been reported that TGF-131 regulates extracellular matrix
(ECM) synthesis, that thromboxane (Tx) stimulates ECM protein
synthesis, and that angiotensin II (Ang II) increases expression of
TGF-f31 mRNA in rat aortic smooth muscle cells. Therefore, we
measured TGF-131 mRNA expression by reverse transcription coupled
with polymerase chain reaction in renal cortex of rats with unilateral
ureteral obstruction (UUO) to determine whether Ang II and/or Tx
stimulates increases in TGF-/31 mRNA. TGF-131 mRNA levels in
contralateral kidneys of rats with UUO did not change significantly
during 14 days of obstruction, while in the obstructed kidney TGF-13l
mRNA levels were increased significantly after three days as compared
to the control (unoperated rats) kidneys. The increase in TGF-/31
mRNA expression in the obstructed kidney cortex was found in tubular
cells rather than glomeruli. OKY-046, an inhibitor of thromboxane
synthase, did not affect the changes in TGF-f31 mRNA in the obstructed
kidney. Enalapril, an angiotensin I converting enzyme inhibitor, signif-
icantly blunted but did not completely abrogate the increase in TGF-131
mRNA. These data suggest that in obstruction TGF-/31 is increased at
the transcriptional level and thus may play a role in initiating fibrogen-
esis in obstructive nephropathy. The effect of thromboxane on extra-
cellular matrix synthesis does not appear to be mediated by TGF-f3l.
Angiotensin II has a role in stimulating TGF-f31 expression in UUO.
Renal interstitial fibrosis is a common consequence of
chronic ureteral obstruction. Fibrogenesis develops as a result
of an imbalance between extracellular matrix (ECM) synthesis,
matrix deposition and matrix degradation [1]. There are several
cytokines secreted by inflammatory cells that stimulate fibro-
blast proliferation and regulate the synthesis of ECM compo-
nents [1]. Among these cytokines TGF-/3l plays a major role in
regulating ECM synthesis [1, 2]. TGF-131 stimulates the synthe-
sis of ECM proteins, inhibits matrix degradation by both an
increase in the activity of protease inhibitors and a decrease in
proteases, and stimulates synthesis of receptors for ECM
proteins [3—5]. TGF-/3 has been shown to regulate gene tran-
scription of collagen types I, III, and IV, fibronectin, laminin
and integrins [1, 3, 5—71. Furthermore, TGF-13 is a chemoattrac-
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tant for fibroblasts [4, 8] and also stimulates fibroblast prolifer
ation [1]. Thus, it may have a role in the accumulation of ECM
proteins in the renal interstitium. However, little is known
about the mechanism of interstitial fibrosis during obstructive
nephropathy, especially in terms of ECM synthesis and its
potential regulation by TGF-/3l.
Several vasoactive compounds that affect renal hemodynam-
ics are increased in acute ureteral obstruction [9, 10]. We
showed previously that two major vasoconstrictors, angioten-
sin II (Ang II) and thromboxane (Tx) A2, play an important role
in the altered renal hernodynamics in this setting. Indeed, prior
inhibition of Ang II and Tx synthesis ameliorated the decrease
in GFR and renal plasma flow seen in the obstructed kidney
[11]. The increased production of prostanoids that occurs in the
obstructed kidney is mediated in large part by the elevated
levels of endogenous Ang II [121. Recently, Ang II has been
shown to modulate proliferation of vascular smooth muscle
cells by stimulating TGF-f3l synthesis [13, 14]. Stouffer and
Owens [14] showed that this smooth muscle cell proliferation is
regulated by Ang II through autocrine production of TGF-f3.
Treatment with Ang II increases TGF-/3 activity while TGF-/3
neutralizing antibody inhibits the Ang IT-induced increase in
DNA synthesis. Gibbons, Pratt and Dzau [13] reported that Ang
II increases mRNA expression of TGF-f3l in cultured aortic
smooth muscle cells and also promotes the conversion of latent
forms of TGF-j31 to the active form. Majesky et al [15] showed
that neointimal thickening after arterial injury is initiated by an
increased synthesis of TGF-f31 through augmented gene expres-
sion. Expression of fibronectin, collagen al(I) and collagen
ct(ITI) mRNA was increased in the neointima after the increase
in cytokine. These studies on vascular smooth muscle indicate
a regulatory effect of Ang II on gene expression for TGF-/31.
Bruggeman et al [16] reported that Tx stimulates ECM
protein synthesis. Thromboxane analogs increased production
of fibronectin, laminin and type IV collagen by human mesan-
gial cells through increased levels of mRNA for these genes.
Others have also shown that Tx stimulates synthesis of ECM
proteins: type IV collagen [17—19], fibronectin [20] and laminin
[17, 20]. However, it is not known whether the stimulating
effect of Tx on ECM is mediated directly or through the
expression of another product such as TGF-/3l.
Thus, the aims of this study were to examine the levels of
mRNA expression for TGF-/3l in the kidney during unilateral
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ureteral obstruction (UUO) and to determine whether or not Tx
and/or Ang II stimulated the expression of TGF-131 mRNA.
Methods
Experimental protocol
Female Sprague-Dawley rats, weighing 200 to 250 g, were
used in this study. Under fluothane anesthesia ureteral obstruc-
tion was performed by ligating the left ureter with 4-0 silk
through a midline abdominal incision. Sham-operated rats had
their ureters manipulated but not ligated; kidneys from these
animals and from unoperated rats served as controls. (Data
from unoperated rats and sham-operated rats were indistin-
guishable.) Rats were sacrificed at 3, 5, 7 and 14 days after
UUO. Under pentobarbital anesthesia (50 mg/kg body wt, i.p.)
the aorta was clamped above the renal arteries and the kidneys
were thoroughly perfused with cold Hanks' balanced salt solu-
tion (HBSS) to cool down the kidneys and to wash out blood
from the renal vasculature and parenchyma. Kidneys were
removed and placed in cold HBSS; the cortex was immediately
dissected from each kidney and stored at —70°C.
A group of rats was given intraperitoneal enalapril (5 mg/kg
body wt), an inhibitor of angiotensin I converting enzyme
(ACE) or OKY-046 (20 mg/kg body wt, Ono Pharmaceutical
Co., Osaka, Japan), an inhibitor of thromboxane synthase at 24
hours, 12 hours, and one hour before ligation of the ureter and
every 12 hours after operation for five days, at which point they
were sacrificed (total of 12 injections). A group of sham-
operated rats was similarly treated with enalapril or OKY-046.
These rats were also sacrificed five days after operation.
RNA isolation
Total RNA was extracted from renal cortex (approximately
50 mg to 100 mg) using guanidinium isothiocyanate (RNAzol
method; CinnalBiotex) [21] and precipitated with isopropanol.
After washing twice with 70% ethanol, the RNA pellet was
dried and dissolved in TE buffer (10 mst Tris, 1 mrsi EDTA).
RNA was quantitated by UV spectrophotometry at 260 nm and
280 nm. RNA with an OD26/OD280 ratio over 1.9 was used for
cDNA synthesis. The ratio was between 2.3 and 1.9 in every
RNA sample regardless of its origin: kidneys of sham-operated
or normal rats, or the contralateral or obstructed kidneys of rats
with UUO.
cDNA synthesis
First-strand cDNA was synthesized using a cDNA cycle kit
(Invitrogen, San Diego, California, USA), 2 g of total RNA
and oligo dT for priming. The reaction was incubated at 42°C for
one hour with a Perkin Elmer Cetus DNA Thermal Cycler,
heated to 94°C for three minutes and chilled on ice. A second
round of reverse transcription was performed after adding 5
units of avian myeloblastosis virus (AMV) enzyme.
Polymerase chain reaction
Polymerase chain reaction (PCR) coupled to reverse tran-
scription of RNA (RT-PCR) has been popular to detect changes
in mRNA levels. With this technique, cDNA synthesis from
total RNA using oligo-dT primer reflects the relative amount of
mRNA and PCR amplification can detect a small amount of
message in a tissue or abundant message in a small amount of
tissue [22]. However, PCR is so sensitive because of exponen-
tial amplification that several kinds of techniques have been
required for quantitation of mRNA [23]. Recently, simpler
techniques were developed to detect mRNA quantitatively by
RT-PCR under optimized conditions for assay [24—271. We used
quantitative RT-PCR for this study by optimizing the conditions
for the amount of total RNA and the number of PCR amplifi-
cation cycles.
Three d of each eDNA was amplified in a total volume of 50
1 containing PCR buffer (50 mivi KC1, 10 msi Tris-HCI), 1.5 mM
MgCI2, 200 M of each dNTP, 50 pmol of oligonucleotide
primers and 1.25 U of Taq DNA polymerase (Promega, Madi-
son, Wisconsin, USA). In order to quantitate the PCR products
comparatively and confirm the integrity of the RNAs we
coamplified a housekeeping gene, glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) in a companion tube. The TGF-/31
primers were designed from the sequence of the rat gene [28]:
5'-AATACGTCAGACATFCGGGAAGCA (sense) from exon 2
and 3 '-GTCAATGTACAGCTGCCGTACACA (antisense)
from exon 6 yield a 498 bp product. The GAPDH primers were
designed from the rat gene: 5'-AATGCATCCTGCACCAC-
CAA (sense) from exon 7 and 3'-GTAGCCATATTCATTGT-
CATA (antisense) from exon 9 yield a 515 bp product [26, 27,
29]. PCR was carried out using a Perkin Elmer Cetus DNA
Thermal Cycler with 30 cycles as follows: 94°C for one minute
(denaturing), 60°C for one minute (annealing) and 72°C for tw
minutes (extension). PCR products were sequenced using t&
TA Cloning System (Invitrogen, San Diego, California, USA)
and the AmpliTaq Sequence kit (Perkin Elmer, Norwalk, Con-
necticut, USA). The resultant sequences (not shown) confirmed
the identity of the ?CR products as TGF-/31 and GAPDH.
Amplification without cDNA did not yield any band other than
those of the primers for TGF-/31 or GAPDH (not shown).
RT-PCR without AMV did not show PCR products, indicating
no amplification of genomic DNA.
The sequence of the fibronectin primers is designed to flank
the EDIIIA region of the rat gene: 5'-GTCAGCGTCTATGCT-
CAGAA (sense) and 3'-TGAGTGAACTTCAGGTrGGTC (an-
tisense) [30—32]. cDNAs were synthesized from 4 pg of total
RNA and 3 sl of each eDNA was amplified with 40 PCR cycles
as follows: 94°C for one minute, 45°C for one minute and 72°C
for two minutes.
Quantitative analysis of PGR products
After amplification, 15 l of each PCR product was electro-
phoresed through a 1.2% agarose gel with ethidium bromide
(0.5 sg/ml). The gel was photographed with Polaroid Type 665
positive/negative film (Polaroid Corporation, Cambridge, Mas-
sachusetts, USA) over UV light at the same exposure and
developing time. The bands on the negative film were scanned
by densitometry (Sepra Scan 2001 software, Integrated Separa-
tions System, Natwick, Massachusetts, USA) for quantification
[26, 27]. The PCR product for TGF-pI or GAPDH amplified
from the same cDNA was electrophoresed in the same gel and
the ratio of TGF-J31/GAPDH was determined to eliminate
gel-to-gel or film-to-film variance.
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Fig. 1. Comparison of densitometric signal against dilution of a PCR
product. A PCR product from bacteriophage lambda DNA (500 bp) was
diluted serially from x 1 to x 1/26. Fifteen microliters of each dilution
were electrophoresed in a 1.2% agarose gel with ethidium bromide,
photographed with a Polaroid negative film and subjected to densitom-
etry. The densitometric signal (arbitrary units) is plotted against
dilution.
Statistical analysis
Data were generated as mean SD and were analyzed by the
unpaired t-test. Comparisons between values for the contralat-
era! and the obstructed kidneys were performed using an
unpaired t-test with Welch's correction.
Results
Quantitation of PCR products
To assess the sensitivity and linear response of the densitom-
etry and the Polaroid film we obtained PCR product from
bacteriophage lambda DNA provided as a control template
(Perkin Elmer) and diluted the PCR product by a twofold
method (1 to 1/26). Each diluted aliquot was electrophoresed
and analyzed quantitatively. Figure 1 demonstrates a good
correlation between the dilution and the relative value of the
density of each band.
To develop optimal conditions for PCR we first synthesized
cDNAs from 8, 4, 2, and 1 g of total RNAs of control kidney.
Three jsl of each cDNA was amplified at 28, 30 and 32 cycles.
A 15-p 1 aliquot of each PCR cycle was electrophoresed through
a 1.2% agarose gel and analyzed quantitatively. PCR products
for TGF-J31 were well correlated with the amount of RNA used
and the number of PCR cycles (Fig. 2A). PCR products for
GAPDH showed a slight increase according to the amount of
RNA and PCR cycles. The densitometric signal for TGF-/31 or
GAPDH approached but was not maximal at 32 cycles (not
shown). Figure 2B demonstrates the relationship between the
amount of total RNA and the relative TGF-fll mRNA expres-
sion (the ratio of TGF-pl/GAPDH). At 32 cycles the ratio
showed a plateau at 4 sg of RNA. At 28 cycles the ratio was
linear but the sensitivity was so low that the variance of the
ratio between 1 and 4 tg RNA was small. At 30 cycles there
was a clear increase in the ratio between 1 and 2 jsg RNA. For
this study we used 2 sg of total RNA for cDNA synthesis and
30 cycles for PCR amplification.
Effects of unilateral ureteral obstruction on the expression of
TGF-f3 mRNA
Figure 3A demonstrates the PCR product at the different time
intervals of UUO. The GAPDH bands of both the contralateral
and the obstructed kidneys showed approximately the same
strength at every time point as that of the control kidney. The
amount of TGF-pl mRNA of the contralateral kidneys of UUO
rats was essentially the same as that of the control kidneys
during the first seven days. The amount of mRNA decreased
slightly at 14 days of ureteral obstruction. The kidneys with
ureteral obstruction showed an increased amount of the
TGF-f31 band at every time point tested as compared to control
kidneys or the contralateral kidney of the same rats. Figure 3B
demonstrates the changes in the relative level of TGF-f31
mRNA expression during UUO. The mRNA expression in the
obstructed kidneys relative to control kidneys or contralateral
kidneys from UUO animals was significantly increased at three
days (2.2-fold of control kidneys), five days (2.4-fold), at seven
days (2.1-fold) and 14 days (2.2-fold). TGF-/3l mRNA level in
the contralateral kidneys of rats with UUO showed a slight (not
significant) increase at three days and at five days. However, it
was slightly decreased at seven days and significantly decreased
at 14 days as compared to that of the control kidneys. We
measured the TGF-/31 mRNA at 4, 8, and 24 hours after UUO.
The TGF-/31 mRNA level was approximately the same between
the contralateral and obstructed kidneys after eight hours.
However, mRNA levels of the housekeeping gene, GAPDH,
were decreased in the obstructed kidney at 24 hours and mRNA
levels of TGF-13l were inconsistent in most cases (not shown).
To determine which cells might contribute to the increased
expression of TGF-pl mRNA in the obstructed kidney cortex,
we measured TGF-f31 mRNA in isolated glomeruli and tubules.
We isolated glomeruli from the renal cortex by mechanical
sieving (mesh sizes 250, 150 and 75 sm) [12]. Tubules were
isolated on the 150 sm mesh, while glomeruli were isolated on
the 75 m mesh. The tubule population includes proximal,
distal, connecting, and collecting tubules. RNA isolation and
RT-PCR were performed as described in the Methods. PCR
amplification was performed using 1 g of total RNA and 28
PCR cycles for glomeruli and 2 sg of RNA and 30 cycles for
tubules. Figure 4 demonstrates the PCR products obtained from
the glomeruli and tubules of rats with UUO for five days. There
was no difference in the level of GAPDH mRNA of the
glomeruli or the tubules between the contralateral and the
obstructed kidneys. TGF-/31 mRNA levels in glomeruli from
the obstructed kidney were essentially the same as those
obtained in glomeruli from the contralateral kidney. However,
TGF-f3l mRNA in the tubules was obviously increased in the
obstructed kidney.
mRNA expression of fibronectin during UUO
To determine whether the increased TGF-f3l contributed to
stimulation of ECM gene expression we carried out PCR to
detect the mRNA expression for fibronectin at five days of
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Fig. 2. Optimization of PCR conditions. cDNA was synthesized
from 8, 4, 2, and 1 j.g of total RNA obtained from control kidneys
28 and amplified at 28, 30 and 32 PCR cycles. A 15 jl aliquot of each
product was electrophoresed and analyzed quantitatively. (A) The
TGF-f31 band shows a significant increase according to the amount of
RNA and number of PCR cycles whereas that of GAPDH shows a
very slight increase. (B) Relative level of TGF-/31 mRNA is
determined by the ratio TGF-131/GAPDH. At 32 cycles the ratio
reaches a plateau at 4 jg of RNA. At 28 cycles the ratio is low but
measurable. At 30 cycles there is a good correlation between the
amount of RNA and the ratio. The optimum conditions were
determined to be 2 g of RNA and 30 cycles of PCR.
UUO. PCR products were electrophoresed in a 2% agarose gel.
Figure 5 demonstrates the PCR products of fibronectin at five
days after UUO. The predicted size for EDIIIA+ and EDIIIA—
was 370 bp and 102 bp, respectively. The EDIIIA+ message
was obviously increased in the obstructed kidney compared to
that message in the control or the contralateral kidney. How-
ever, the amount of the EDIIIA— message was approximately
the same in the three types of kidneys tested. There was also a
PCR product of 290 bp which by limited restriction enzyme
digestion was also shown to be a product of the fibronectin gene
(not shown). The amount of this product was not significantly
changed by ureteral obstruction.
Effects of enalapril or OKY-046 on the expression of TGF-131
mRNA
We treated rats with enalapril or OKY-046 for one preoper-
ative and five postoperative days to determine whether or not
increased angiotensin II or thromboxane levels had a role in the
increase in TGF-/31 mRNA in obstruction. These two inhibitors
did not affect the levels of mRNA GAPDH in any experiment.
Figure 6 demonstrates the effects of enalapril or OKY-046 on
the mRNA levels of TGF-13l in obstructed kidneys of UUO rats
relative to contralateral kidneys from those animals. The in-
creased level of TGF-f31 mRNA present in the obstructed
kidney was significantly blunted though not completely abro-
gated by perioperative treatment with enalapril (mRNA for
TGF-13 decreased from 2.2-fold to 1.7-fold of the level of the
control kidneys). There was still a significant difference in the
mRNA level between the contralateral and the obstructed
kidneys of rats given enalapril. TGF-/31 mRNA levels in the
contralateral kidneys were not affected by enalapril. Treatment
with enalapril had no effect on the mRNA levels of TGF-31 in
kidneys of sham-operated rats (data not shown).
The mRNA levels of TGF-pl in the obstructed kidneys of
untreated rats were not significantly affected relative to levels in
kidneys of rats treated with OKY-046 (Fig. 5). Thus, OKY-046
did not suppress the increased levels of TGF-/31 mRNA present
in the obstructed kidneys. The mRNA level of TGF-/3l in the
contralateral kidneys was also not affected by OKY-046 admin-
istration. Sham-operated rats treated with OKY-046 showed
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similar levels of TGF-131 mRNA in their kidneys as those of
sham-operated animals which did not receive OKY-046 (data
not shown).
Discussion
The steady-state levels of mRNA for TGF-f31 in rat kidney
have been shown to be high in glomeruli, intermediate in papilla
and low in cortex and whole kidney [33]. We used RT-PCR to
detect mRNA for TGF-f31 in renal cortex. We first explored the
conditions that would optimize the detection of TGF-/31 mRNA
(ratio of TGF-131/GAPDH) in control kidneys and kidneys with
ureteral obstruction. In preliminary experiments we determined
parameters to obtain a correlation between serially diluted PCR
products and their densitometric signals. Although the exact
amount of amplified DNA cannot be determined in an ethidium
bromide stained gel, we believe this technique is useful to
— TGF-J31
—GAPDH
Fig. 3. Representative changes of TGF-/31 mRNA expression during
UUO. RT-PCR was performed under optimum conditions. Fifteen
microliters of each PCR product was electrophoresed, photographed
and analyzed quantitatively. (A) The amount of GAPDH mRNA is
approximately the same at every time point. The amount of TGF-/31
mRNA in the obstructed kidney is increased after UUO when
compared to the control kidney. Abbreviations are: N, control
kidney; C, contralateral kidney; 0, obstructed kidney; D, days. (B)
The level of TGF-f31 mRNA in the obstructed kidney is significantly
increased relative to contralateral kidneys of obstructed rats. The
ratio on the vertical axis refers to TGF-/31/GAPDH. TGF-/31 mRNA
in the contralateral kidney is slightly decreased at seven days, and is
significantly decreased at 14 days as compared to the control kidney.
There is a significant difference between the contralateral and the
obstructed kidney at every time point (P < 0.001). Abbreviations are:
N, control kidney; C, contralateral kidney; 0, obstructed kidney. Bar
represents mean SD. N = 5. * P < 0.001 and ** p < 0.05 versus
control kidneys. # P < 0.01 and ## P < 0.05 versus contralateral
kidneys at 3 days or 5 days.
measure relative mRNA levels under optimized conditions from
small amounts of kidney tissue.
We showed that in the obstructed kidney the expression of
TGF-131 mRNA was increased significantly at 3, 5, 7 and 14
days after UUO. Nagel and Bulger [34] reported that in rabbits
with UUO the interstitial space was widened at seven days after
obstruction; there were increased collagen fibers and numerous
fibroblasts detected at this time, and by the 16th day collagen
was greatly increased and was arranged in large bundles. These
pathological findings indicate that the process of renal intersti-
tial fibrosis after ureteral ligation may be initiated at seven days
or earlier after the onset of obstruction. Khalil et al [35] showed
in a rat model of bleomycin-induced pulmonary fibrosis that the
peak level of TGF-$, which occurred at seven days after
bleomycin administration, preceded the maximum collagen
protein synthesis, which occurred seven days later. Others [15]
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Fig. 4. TGF-g31 mRNA expression in
glomeruli and tubules aft erfive days of UUO.
Glomeruli and tubules were isolated with a
sieve technique and mRNA expressions for
TGF-/3l and GAPDH were measured. Results
are from two different experimental animals.
The TGF-j31 mRNA level did not differ in
glomeruli from the contralateral and
— GAPDH obstructed kidneys but increased in tubules
from obstructed kidneys. The center lane
presents a size marker of DNA. Abbreviations
are: G, glomeruli; T, tubules; C, contralateral
kidney; 0, obstructed kidney.
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Fig. 5. mRNA expression of fibronectin after five days of UUO. PCR
was carried out using the primers flanking the EDIJIA region of
fibronectin gene. The 370 bp band (EDIIIA+) was increased in the
obstructed kidney while the 290 and 102 bp bands (EDIIIA—) were
essentially unchanged. Abbreviations are: S, kidney from sham-oper-
ated rats; C, contralateral kidney; 0, obstructed kidney.
have demonstrated that during vascular injury the increase in
mRNA for TGF-j31 preceded the increase of mRNAs for
collagen and fibronectin and the thickening of the vascular wall.
We demonstrated that the expression of the EDIJIA region of
fibronectin mRNA was increased in the obstructed kidney at
five days after UUO. Fibronectin mRNA is alternatively spliced
to yield several isoforms of fibronectin [32]. Among several
splicing alternates of fibronectin mRNA the EDIJIA region has
been shown to be regulated by TGF-f3 [30, 36]. Thus, it is
conceivable that the increased expression of TGF-J3l mRNA in
the obstructed kidney may result in an increase in ECM protein
synthesis in the renal cortex during UUO.
Fig. 6. Effects of enalapril or OKY-046 on TGF-131 rnRNA expression
after five days of UUO. The ratio on the vertical axis refers to
TGF-/31/GAPDH. Enalapril significantly blunted the increased level of
TGF-/3l mRNA seen in the obstructed kidney while it did not affect the
level in the contralateral kidney. The difference in TGF-/3 mRNA
expression between contralateral and obstructed kidneys was still
significant in enalapril-treated rats. OKY-046 did not affect the level of
TGF-/31 mRNA seen in either the obstructed or contralateral kidneys.
There was a significant difference between the two kidneys in untreated
rats and in those treated with OKY-046 (P c 0.001). Abbreviations are:
N, control kidney; C, contralateral kidney; 0, obstructed kidney; ENL,
enalapril; OKY, OKY-046. Bar represents mean SD. N = 5 * J c
0.001 and ** p C 0.01 versus control kidneys.
Walton et al [37] reported that the expression of mRNA for
TGF-/3 was increased at 48 hours after UUO and speculated
that this change may have a bearing on the development of
apoptosis of renal tubular cells due to a role of TGF-f3 in
suppressing cell growth. At present there is no evidence that
could explain how TGF-j31 might participate in inhibiting cell
growth and/or stimulating ECM synthesis in obstructive ne-
phropathy. Howe, Cunningham, and Leof [38] demonstrated
P.cO.01 Pc0.05
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that c-cis and c-myc mRNA expression in cultured fibroblasts
following TGF-f3l stimulation was abolished by pertussis toxin,
while the increase in collagen and fibronectin mRNA were not
affected. These data suggest that TGF-pl may play a role in the
stimulation of gene expression through multiple pathways.
Thus, it remains to be explored whether gene expression of
ECM proteins is stimulated after the increase in TGF-pl mRNA
during UUO.
We found that the contralateral kidney of rats with UUO
showed a decrease in TGF-pl mRNA level over seven days,
and the level at 14 days was significantly lower than that in the
control kidneys. TGF-pl is considered to be one of the factors
that modulates renal hypertrophy. However, molecular mech-
anisms of renal hypertrophy and hyperplasia have not been well
elucidated and several growth factors and protooncogenes may
modulate renal enlargement [reviewed in 39]. Thus, at present it
is not clear whether or not TGF-f31 has a role in the renal
compensatory hypertrophy observed in the contralateral kidney
after UUO. It may be that the increase in TGF-/3l synthesis is
localized to the obstructed kidney and that increased TGF-/31
levels in this kidney may act both as an autocrine and a
paracrine factor.
In this study we have not identified the mechanisms by which
TGF-/31 mRNA is increased during UUO. It is well known that
inflammatory cells have an important role in the fibrogenic
process; they activate proliferative and migratory fibrogenic
responses in resident cells and secrete several cytokines which
regulate ECM synthesis [1]. Macrophages have been shown to
produce and secrete TGF-131 [35, 40, 41], which might have
chemotactic activity for monocytes [42] and have a role in
strong stimulation of fibroblast proliferation [1]. Jones et al [43]
reported that the number of interstitial macrophages correlated
with the increased ECM protein synthesis in purine aminonu-
cleoside nephrosis. Our previous report demonstrated that
leukocytes, predominantly macrophages, infiltrate the renal
interstitium after UUO and at 24 hours the influx stabilized at a
level approximately 10-fold higher than normal [44]. We were
not able to consistently measure mRNA expression for TGF-/3l
at 24 hours after UUO because both the GAPDH and the
TGF-j31 mRNA expression were unstable in the obstructed
kidney at this time point. The expressions of TGF-/3l and
GAPDH, however, were the same between the contralateral
and obstructed kidneys for at least eight hours. It may be that
general RNA transcription declines and/or an increased expo-
sure to nucleases occurs during the first 24 hours of ureteral
obstruction. Nagel, Johnson and Jervis [45] also demonstrated
that both mononuclear cells and fibroblasts are clearly in-
creased at 72 hours after UUO. From these data it is conceiv-
able that macrophages may be responsible for the increased
expression of TGF-pl mRNA during UUO. Epithelial tubular
cells or glomerular cells may be other sites of gene expression
for TGF-131 because steady-state mRNA for TGF-/3l was
confirmed in the control kidneys, where macrophages should
not have infiltrated, and because gene expression of TGF-131
has been shown in cultured proximal tubular cells [46] and in rat
glomeruli [33]. We found that TGF-f3l mRNA expression in the
obstructed kidney was increased in renal cortical tubules rather
than in glomeruli after five days of UUO. This suggests that
renal tubular cells may contribute to the increased TGF-/3l
expression in the obstructed kidney. While TGF-/31 is consid-
ered to be one of the causative cytokines of increased ECM
synthesis in glomerular sclerosis [47], the fact that the glomeruli
in the obstructed kidney did not show an increased TGF-/31
mRNA level may be consistent with the fact that the glomeruli
appear normal by light microscopy through seven days of
obstructive nephropathy [48]. In a ureteral obstructed rat
kidney model glomeruli appeared normal by light microscopy at
day 15 although there was marked interstitial fibrosis [49]. The
collagen content of the ureteral obstructed kidney of this rat
model was increased threefold. These suggestive findings not-
withstanding, it remains to be determined whether the in-
creased gene expression of TGF-pl during UUO is accounted
for by macrophages and/or resident renal cells. Our determina-
tions measured TGF-131 mRNA content over the whole renal
cortex. In situ hybridization would precisely locate the cells
where TGF-pl expression is increased.
We found that enalapril, an inhibitor of ACE, significantly
blunted the increase in TGF-f31 mRNA in obstructed kidneys
although it did not return the levels to those seen in kidneys of
sham-operated or normal rats. In vascular injury Ang II has
been shown to induce increased levels of TGF-/31 mRNA and
promote the conversion of latent TGF-/31 to its biologically
active form [13]. Thus, Ang II may have a role in stimulating
expression of TGF-f3l mRNA in UUO and in increasing the
number of active forms of TGF-f31 in this setting. Horikoshi et
al [50] reported that water deprivation in mice, which induced
an increase of plasma renin activity, did not increase TGF-j3l in
juxtaglomerular apparatus or renal tubular cells but did increase
TGF-132 expression specifically in the juxtaglomerular appara-
tus. This suggests that elevated levels of circulating renin or
Ang II might not affect TGF-pl expression in kidney. There-
fore, localized production of Ang II may contribute to the
stimulation of TGF-131 mRNA during UUO. Recent studies
from the laboratory of Border and Ruoslahti have implicated
TGF-/3 as an initiating factor in the development of glomerular
sclerosis [reviewed in 51]. Whether Ang II is a causative factor
in the increase in TGF-13 in those models of glomerulonephritis
is presently not known. It should be pointed out, however, that
a low-protein diet apparently decreases the expression of
TGF-/3 within the glomerulus [52]. This dietary maneuver in
turn has been shown to decrease the apparent amount of renal
Ang II [47]. However, other mechanisms may also regulate
TGF-f3l mRNA expression during obstruction because the
increased levels of TGF-f3l mRNA were not suppressed by
enalapril to the levels seen in kidneys of control rats.
We also showed that OKY-046, an inhibitor of Tx synthase,
did not modify the increased level of TGF-/31 mRNA present in
the kidney with ureteral obstruction of five days duration. This
implies that the stimulatory effect of Tx on ECM synthesis [16]
may not be mediated through TGF-f31 transcription. However,
Tx may modulate TGF-131 synthesis at a post-transcriptional
level or Tx may stimulate directly the gene expression of ECM
proteins [16, 17].
In summary, we have demonstrated that mRNA levels of
TGF-/3l are significantly increased in the obstructed kidney
three days after UUO as compared to the contralateral kidney
of the same rats or control kidney. An ACE inhibitor signifi-
cantly blunted the increased level of TGF-J31 mRNA present in
the obstructed kidney at five days after UUO. Tx synthase
inhibitor did not affect the increased level of TGF-/31 mRNA.
320 Kaneto et al: TGF-f31 mRNA in the obstructed kidney
These data suggest that TGF-f31 might be increased at the
transcriptional level soon after UUO, that the effect of Tx on
ECM synthesis might not be induced at the gene transcriptional
level of TGF-/31, and that Ang II might have a role in stimulat-
ing TGF-/31 mRNA expression in UUO.
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